Gonorrhea Symptoms: Recognition, Testing, and Treatment
Gonorrhea is a common sexually transmitted infection (STI) caused by Neisseria gonorrhoeae. Many infections are asymptomatic, especially in women, making screening critical.
Symptoms by Site
Urogenital — Men
- Urethral discharge (white, yellow, green; purulent)
- Dysuria (burning on urination)
- Urinary frequency/urgency
- Testicular/epididymal pain/swelling (epididymitis)
Urogenital — Women
- Often asymptomatic
- Increased vaginal discharge (yellow/green)
- Dysuria
- Intermenstrual or postcoital bleeding
- Lower abdominal/pelvic pain (suggests PID)
- Fever, nausea (if ascending infection)
Rectal (All Genders)
- Often asymptomatic
- Discharge, bleeding, pruritus, tenesmus, pain
Pharyngeal
- Usually asymptomatic
- Sore throat, exudates (rare)
Conjunctival (Neonatal/Adult)
- Purulent conjunctivitis, eyelid edema — ophthalmia neonatorum in newborns
Complications of Untreated Infection
- Women: PID, tubal factor infertility, ectopic pregnancy, chronic pelvic pain, Fitz-Hugh-Curtis syndrome (perihepatitis).
- Men: Epididymitis, infertility, prostatitis.
- Disseminated gonococcal infection (DGI): Arthritis-dermatitis syndrome (migratory arthralgia, tenosynovitis, pustular rash), septic arthritis, endocarditis, meningitis.
- Neonatal: Ophthalmia, sepsis, scalp abscess.
- HIV risk: Gonorrhea increases HIV acquisition/transmission 3–5 fold.
Diagnosis
- NAAT (nucleic acid amplification test) on urine, urethral/cervical/vaginal/rectal/pharyngeal swabs — gold standard.
- Culture (for antibiotic susceptibility) if treatment failure or DGI.
- Gram stain (urethral discharge in men: gram-negative intracellular diplococci = presumptive).
Treatment (CDC 2021 Guidelines)
- Uncomplicated urogenital/rectal/pharyngeal: Ceftriaxone 500 mg IM single dose (1 g if ≥150 kg).
- If chlamydia not excluded: Add doxycycline 100 mg PO BID × 7 days.
- Allergy to cephalosporins: Gentamicin 240 mg IM + azithromycin 2 g PO (single dose).
- DGI: Ceftriaxone 1 g IV/IM q24h × 24–48h after improvement, then oral step-down.
Follow-Up
- Test-of-cure at 7–14 days if pharyngeal infection or alternative regimen used.
- Retest at 3 months (high reinfection rate).
- Partner notification and treatment (expedited partner therapy where legal).
- HIV/syphilis testing at diagnosis.
Prevention
Consistent condom use, mutual monogamy with tested partner, regular STI screening (annually for sexually active <25, or per risk), PrEP for HIV prevention does not protect against gonorrhea.
Gonorrhea - Related Articles
- Posterior Placenta Grade 2: Partial Cervical Coverage and Previa Risk
- Gonorrhea in Men vs. Women: Symptom and Complication Differences
- Gonorrhea and the Digestive System: Not a Typical Association
- Gonorrhea: Immediate Symptoms and Potential Complications
- Aspiration Biopsy: Understanding the Procedure & Its Uses
- Sinus Infection: When to See a Doctor
- Afterbirth: Understanding the Placenta After Childbirth
